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INTRODUCTION 
 1 
INTRODUCTION 
 Coronary artery disease has been considered as the important cause 
of death in industrialized nations. 
 Acute coronary syndrome (ACS) includes STEMI and NSTEMI 
and unstable angina. The important risk factors for ACS are type 2 
Diabetes Mellitus (DM), insulin resistance, obesity, cigarette smoking, 
hypertension, and dyslipidemia.  
Unlike other cardiovascular risk factors, obesity and type 2 
diabetes are showing a significantly rising pattern.Uncontrolled diabetes 
has high incidence of ACS and poor prognosis. Higher blood sugar value 
during admission for ACS carries grave prognosis not only in diabetics, 
but also in non diabetes patients. 
Compared to other risk factors of cardiovascular diseases such as 
elevated serum lipid levels, cigarette smoking, and hypertension, that are 
decreasing or better under proper management & control with medicine, 
obesity & type 2 diabetes are exihibiting increasing trends.(1) 
 Coronary artery disease which is being considered as the most 
significant complication of DM, presents two to four folds greater risk of 
mortality compared to the non-diabetic population.(2) Patient with 
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diabetes have coronary artery disease much earlier & they show 
comparatively more wide spread atherosclerosis.(3) 
 Diabetes Mellitus has been recently considered as an important 
cardiovascular disease risk factor in the similar group which includes 
smoking, increased blood pressure and dyslipidemia by American Heart 
Association. 
 The Framingham heart study also revealed a marked increased in 
coronary artery disease, myocardial infarction, congestive heart failure 
and sudden death in diabetes. 
 The age matched risk of the above cardiovascular disease is twice 
in men with DM when compared to those without diabetes.(4) 
 The Diabetes is showing a rising incidence in the Indian scenario 
due to ageing of the people and due to high rates of obesity & sedentary 
living pattern.  
 Patients with type 2 diabetes who do not have a previous incidence 
of ACS carry the same risk for coronary artery disease as individuals 
without diabetes who had suffered a previous episode of ACS.(2)  Hence, 
diabetes should be regarded as an important cause for  cardiovascular 
disease (CVD) & its position should be along with the other known risk 
factors for CVD. Thus it might be appropriate to say, "Diabetes is a 
cardiovascular disease. (5)  
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Out of 4 patients, nearly one patient with ACS has presented with a 
diabetes history according to Global Registry of Acute Coronary Events. 
Mostly these individuals belonged to the female gender and they had 
increased mortality rate; most of them were older age and non smokers. 
The Framingham Study also confirms that the females had a higher 
occurrence of diabetes compared to males. (6,4) 
In acute MI, DM has been a bad prognostic factor with an 
increased occurrence of heart failure, higher mortality in the hospital, 
conduction abnormalities including atrial fibrillation & post-infarction 
angina among diabetics. (7,8) 
 It has been shown that adequate control of the blood sugar brings 
down the progression of microvascular disorder caused by diabetes. 
However, its influence on macrovascular complications is not well 
known. (9) 
 Glucose control may reduce microvascular complications such as 
nephropathy, retinopathy. This is not so true with cardiovascular adverse 
effects. 
 In microvascular complications also, control of hypertension has a 
better effect than control of blood sugar which independently reduces 
cardiovascular complications.(10,11)  
 4 
 In uncontrolled cases the condition is grave! According to the Paris 
Prospective Study, the incidence of death significantly became higher 
with rising fasting as well as two-hour blood sugar value.(12)  
 Poor blood control have high incidence of ACS which inturn have 
poor outcome. Also it is seen that hyperglycemia without history of DM 
are not uncommon in patients presenting with ACS.(13) Inadequate 
glycemic management is shown by elevated HblAC, and its elevated 
value during admission for ACS, increases the mortality in first month. 
Also hyperglycemia at the time of ACS without the history of DM has 
increased short term mortality.(14) 
Diabetes is a significant risk factor for the development of ACS & 
the adverse outcome after ACS. ‘Stress hyperglycemia’has been defined 
in different ways by various studies Transient hyperglycemia has been 
recognised as a noticeable feature in ACS and is considered to be related 
to stress (Lakhdar et al., 1984).(15) Sometimes, hyperglycemia can 
denote pre-existing type 2 diabetes or impaired glucose tolerance which 
has not been detected before.  
Infact increased blood sugar can be an indicator of already 
prevailing insulin resistance & defective function of beta cell which can 
result in bad prognosis. Recently hyperglycemia has been related to 
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increased mortality in diabetic as well as in non diabetic and to an 
increased incidence of cardiogenic shock (Oswald et al., 1984).(16) 
 Studies clearly prove that uncontrolled blood sugar has poor 
outcome when they develop an ACS, but the hyperglycemia at the time of 
ACS also have similar prognostic value. (17) 
 We were interested to know what determines the prognosis in a 
patients admitted for ACS - a persistent high blood sugar level as 
determined by HbA1c or hyperglycemia noted during the admission. 
 
 
 
 
  
 
 
 
REVIEW OF 
LITERATURE 
 6 
REVIEW OF LITERATURE 
CORONARY ARTERY DISEASE 
INCIDENCE AND PREVALENCE 
Disease of the coronary arteries is the most significant and life-
endangering problem that occurs in diabetic individuals. Diabetics have a 
2 to 4 times increased risk for CAD compared to non diabetic 
counterparts. 
 Cardiovascular disease is the cause for nearly twelve million deaths 
yearly & is the important reason of death worldwide. 
 Previously considered as a disease of the affluent, the past three 
decades have seen considerable decline in the incidence and prevalence 
of atherosclerotic coronary artery disease in the industrialized western 
world, whereas at the same time this problem is assuming epidemic 
proportions in the developing world. 
There was a sudden rise in the global prevalence of coronary artery 
disease in the last century. Global Burden of Disease Study has shown 
that our nation suffers the highest burden of ischemic heart disease.  
Though decrease in deaths due to coronary artery disease is seen in 
various developed countries, the pattern has been shown to be reversed in 
developing nations. The above observation is perhaps due to 
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epidemiological  transition happening in those countries. Apparently, the 
total coronary artery disease deaths from China & India is equivalent to 
the total deaths due to coronary artery disease happening in all developed 
nations. A significant ethnic variability is clearly demonstrated in the 
occurrence of coronary artery disease.  It has also been proved that there 
is an increased incidence of premature ischemic heart disease in Indians. 
 Asian Indians, whether living in their own country or elsewhere 
have much higher incidence of CAD as compared to all other ethnic 
groups. 
 CAD among Asian Indians have been found to be more severe, 
diffuse and associated with serious complications and increasing 
mortality at a younger age. 
Coronary artery heart disease related death was an uncommon 
cause of death in United States at the beginning of the last century, 
constituting less than ten percentage of total mortality in the year 
1910.Mortality level due to CAD rose to 55% of all deaths by the year 
1965. The last three decades saw an yearly fall of CAD in the US. 
 While in India from the 1960's to the 1990's the prevalence of 
coronary artery disease became elevated to 2 fold (two percentage to four 
percentage) in people living in rural areas and 3-fold (3.4% to 9.45%) in 
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Urban populations. The prevalence is even higher in South India (13% 
urban and 7% rural). 
 In 1990, 25% deaths in India were attributable to cardiovascular 
disease compared to 9% due to diarrheal disease, 12% due to respiratory 
infections and 5% due to tuberculosis.(18) 
 In India,the pattern of CAD is developing earlier when compared 
with the age incidence of nations which are considered as developed 
nations. Incidence in men are greater than females with the time of peak 
occurrence being observed as from fifty one to sixty years. Elevated 
blood pressure and blood sugar are the reasons for nearly fourty percent 
of total cases, and high prevalence of smoking is seen in significant 
amount of cases.(19) 
RISK FACTORS 
Atherosclerotic CAD is a fatal disease with no known cure. 
However, it is preventable and treatable. The National Heart Lung and 
Blood Institute of USA initiated the Framingham Heart Study in 1949 
and by 1961 &the concept of risk factors for CHD was clearly made out. 
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RISK  FACTORS ASSOCIATED WITH THE  DEVELOPMENT 
OF CAD 
 
Non Modifiable 
Risk Factors 
Age 
Male gender 
Family History 
 
Modifiable risk 
factors 
Smoking 
Obesity 
Diabetes 
High blood 
pressure 
Increased 
Cholesterol 
Nature of 
behaviour 
 
Newer risk factors 
 
Atherogenic risk factors 
Lipoprotein(a) 
Elevated Homocysteine level 
Plasma fibrinogen 
Tissue plasminogen activator 
Plasminogen activator inhibitor-1 
C-Reactive protein 
 
Hyperlipidemia, elevated serum glucose, increased blood pressure, 
smoking and family history of premature CAD are proven to be the 
classically defined risk factors for atherosclerotic coronary artery disease. 
Newer risk factors include CRP, homocysteinemia and lipoprotein (a). 
In ethnic Asian Indians the insulin resistance syndrome( otherwise 
known as metabolic syndrome X), lipoprotein(a), atherogenic 
dyslipidemic phenotype and some newer emerging risk factors 
(homocysteine, tPA PAI-I, fibrinogen , factor VII, infections and 
inflammation ) may be more relevant.The underlying genetic 
susceptibility associated with a modest abnormality in lipid and lifestyle 
factors makes CAD assume a malignant course in Asian Indians.(18) 
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DIABETES MELLITUS 
Diabetes is being widely recognised as a major disease of the 
world. At present it is prevalent in an estimated 143 million individuals 
globally & its rate is showing a faster growth. About 1-5% Indians have 
type 2 diabetes are associated complication. 
Based on the statistics of last 2 decades, incidence of DM has 
increased worldwide in drastic proportions, from thirty million in 1985 to 
one hundred and thirty seven million in 2000. According to the present 
trend, more than three hundred& sixty million people might be suffering 
from diabetes by 2030. 
Even if both type 1 & type 2 diabetes are having a high occurrence 
world wide, there is a faster growth in incidence of type 2 DM due to 
higher obesity rates and decreased activity pattern .This occurs as nations 
tends to be more industrialized. 
This trend appears to be real in most of the countries.  In fact  out 
of the top ten countries with higher rates of DM, six are in Asia. It has 
been  estimated that in the United States 20.8 million people (7% of the 
individuals) suffered from diabetes in 2005, by the centres for disease 
control and prevention (CDC).  In fact nearly 30% of them were 
undiagnosed. 
 
 11 
Diabetes has been listed as the 6th major cause of death in the 
United States and globally 3 million deaths occur per year.(20) 
Criteria for the diagnosis of Type II Diabetes Mellitus (ADA 
criteria) 
Blood glucose in the fasting state greater than or equal to 126 
mg/dl (7.0 mmol/l)  
OR 
Classical Symptoms (such as increased frequency of urination, 
increased thirst, weight loss which can not be explained) and 
A random value of blood glucose greater than or equal to 200 mg/dl (11.1 
mmol/l)  
OR  
Blood glucose value greater than or equal to  200 mg/dl ( 11.1 
mmol/l) which is taken two hours after giving a seventy five gram 
glucose load  
OR  
HbA1c ≥ 6.5%. 
DIABETIC BURDEN IN INDIA 
 In India diabetes has become an important public health issue .It 
has been reported by WHO that there were 31.7million people with 
diabetes in our nation in 2000 & this rate might become 71.4 million in 
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2030. India has turned out to be the diabetic capital with the highest 
number of diabetics in the world. 
 A greater incidence of type 2 DM was noticed among Indians who 
have migrated to other countries for various reasons, when compared 
with their native population, suggesting that Indians as an ethnic group 
had a genetic propensity to develop diabetes which was precipitated by 
life style changes. 
 Among the Indians living in the urban areas present rate of DM is 
12.1%.Datas show that type 2 DM occurs at a younger age amongst 
Indians, a decade earlier than in the West. 
 Decline in productivity has occurred as a result of higher rates of 
morbidity & mortality due to the earlier age of onset, late diagnosis and 
inadequate care.(21) 
DIABETES AND CORONARY ARTERY DISEASE 
 Diabetics show a greater propensity to develop CAD much earlier 
than non diabetics and atherosclerotic process in them tends to be more 
wide spread indicating that the cardiac disease in Diabetic individuals is 
not similar to that occuring in non diabetics. 
According to Multiple Risk Factor Intervention Trial diabetic 
population with out the conventional risk factors like elevated blood 
pressure, hypercholesterolemia or smoking had a 4.4 times higher rates of 
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cardiac deaths when compared with the control subjects of the 
corresponding age. But patients having HbA1c level less than 6.0% had 
only a small incidence of CAD.(22) 
According to the twenty years of surveillance observed in the 
Framingham cohort study,it has been reported to have a two-fold to 3 fold 
greater chance of atherosclerotic disorder prior to evidence of Diabetes. 
Diabetic females had a greater rates of morbidity & mortality than for 
non-diabetic males , for each of the CVD.Diabetic females had a similar 
high CVD mortality rates when compared with the diabetic males.(23) 
  Diabetic men had a greater risk of CVD death than non-diabetic of 
all age group, ethnicity, and risk factor level which was shown by a 
similar study. A 3 times greater rate has been observed after adjustment 
for age, race, income, systolic BP, serum lipid level and reported quantity 
of cigarettes per day. A progressive rise in absolute risk of CVD death 
was observed in diabetic men with higher risk factor than for non diabetic 
men with similar risk factor levels.(24) 
The risk of CVD is substantially higher in diabetic population. 
Compared to euglycemic individuals, diabetics carry a worse prognosis 
when clinical cardiovascular disease sets in. Hyperglycemia, by causing 
defects in endothelium, contributes to atherosclerotic pathogenesis 
directly. 
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  Elevated blood glucose is a predominant risk factor for formation 
of cholesterol plaques and subsequent atherogenic mechanism, 
hyperlipidemia & it is frequently related with high blood pressure, 
dysfunction of endothelial cells, defective adhesion & aggregation of 
platelets, coagulation defects and greater oxidative stress. 
Atherogenic dyslipidemias tend to be seen in type 2 diabetes. 
Metabolic syndrome which was previously called as syndrome X 
includes hyperlipidemia, raised blood pressure & a procoagulant 
condition apart from the abnormalities in the metabolism of blood 
sugar.Generally type 2 diabetes or the insulin resistance disorder is seen 
as a part of metabolic syndrome. Apart from smoking, almost the entire 
group of  risk factors of cardiovascular disease seem to be very much 
common in type 2 diabetes individuals. 
INSULIN RESISTANCE 
Diabetic population have an enhanced potential to develop CAD. 
However, this could not be totally substantiated by the increase of 
conventional risk factors such as hypertension & hyperlipidemia. But in 
diabetics the above mentioned factors are proven to be enhanced. A 
condition of persistently elevated insulin & blood sugar level 
(hyperinsulinemia & hyperglycemia)  has occurred because of the insulin 
resistance & the subsequent rise in the production of insulin as a part of 
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compensatory mechanism. Hence its appropriate to say insulin resistance 
acts as a predecessor of development of DM. 
Reaven (25)analysed the relationship of insulin resistance & CAD 
and he pointed out that DM is seen as  a component of the insulin 
resistance syndrome ( known as metabolic syndrome), that comprises 
elevated blood sugar, disorders of lipid metabolism and truncal obesity. 
Based on the European Group of Insulin  Resistance criteria, Insulin 
Resistance Syndrome has been described and accordingly, a prevalence 
rate of 11.2 percentage has been found in South Indians. 
MECHANISM OF ATHEROSCLEROTIC PROCESS IN 
DIABETES 
 
Relationship between high blood sugar, abnormalities of the 
endothelium and atherogenic  process is well understood. In diabetes, the 
initial prominent atherogenic change is endothelial dysfunction. It 
includes deranged endothelium mediated vasodilation, which might 
lead to decreased blood supply& its subsequent consequences by 
preventing dilatation as well as proliferation of smooth-muscles of blood 
vessels,enhanced thrombogenesis and proatherogenic cellular processes.  
In type 2 DM,there is an established association between the raised 
plasma glucose level & atherosclerosis. Almost all proteins undergo 
glycosylation as a result of elevated glucose level. This is causing cross 
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linkages of collagen and various extra cellular matrix proteins which are 
seen in the walls of arteries. Prolonged exposure to increased plasma 
sugar values itself will result in defective function of endothelium. 
Everything including elevated blood pressure & cholesterol value, 
enhanced atherosclerotic process and thrombus formation, contribute to 
the underlying pathophysiology of vascular problems in diabetes 
individuals. Perhaps it might be the basic defects in endothelial function 
which is responsible for all these disorders of vascular system. 
DIABETIC CONTROL AND CARDIOVASCULAR EVENTS 
 In patients having established DM, whether adequate blood sugar 
control alone decreases CVD is an unanswered puzzle. 
 The diabetic control and complications trial (DCCT) failed to 
establish a notable decrease in cardiac diseases with adequate control of 
glycemic status in young subjects with type1 DM. However 
epidemiology of diabetes interventions and complications (EDIC) 
trial,which was considered as a follow up study ,succeeded in establishing 
a delayed benefit.(26) 
In various trials it has been observed that adequate glycemic 
management in subjects with type 2 DM decreases the acceleration of 
microvascular disorder. However, its impact on macrovascular 
abnormalities is not clear (27) 
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 Two recent studies that include Action in Diabetes and Vascular 
Disease (ADVANCE) trial(28) and the Action to Control Cardiovascular 
Risk in Diabetes (ACCORD) trial(29)  failed to observe any significant 
decrease in cardiac incidents with adequate glycemic management. 
Baseline values of HBA1C were 7.2 percentage in ADVANCE 
study and 8.1 percentage in the ACCORD study. After intensive therapy, 
glycated hemoglobin levels were reached 6.4% in both studies. 
Following adequate treatment strategy, the values became 7.5 
percentage & 7.0% respectively. But these trials failed to establish a 
significant reduction in cardiac incidents. Greater rate of hypoglycemia 
and increase in body weight was noticed in subjects who were under 
intensive control. There was not much impact on microvascular 
consequences by intensive blood sugar monitoring over a duration of five 
to 6 years. 
 Adequate blood sugar management, if started in the initial phase of 
disease, might bring out advantageous effect. But it is essential to avoid 
severe hypoglycemia. Hence proper control of blood pressure, 
elevated lipid level and other cardiovascular risk factors can be 
considered as the efficient strategy for the prevention of CVD among the 
diabetes.(30) 
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ACUTE CORONARY SYNDROME 
By definition ACS comprises a spectrum of cardiac events which 
consist of STEMI,NSTEMI & unstable angina.It is diagnosed  with the 
help of ECG,proper history that includes the clinical features and 
symptoms of ischemia and with the analysis of cardiac biomarkers. The 
usual ECG changes include T-wave tenting or inversion, ST-segment 
elevation or depression & pathologic Q waves. 
INCIDENCE OF ACS IN DIABETES MELLITUS 
 Haffner(2) studied seven year incidence rate of ACS in patients 
with diabetes and prior history of myocardial infarction. The 7 year 
incidence levels of ACS among non-diabetic population with & without 
previous episode of MI at baseline has been observed as 18.8% and 3.5 
%, respectively (P<0.001). The 7 year incidence levels of ACS in diabetic 
groups with & without previous episode of MI were 45% & 20.2%, 
respectively (P<O.001). Thus the myocardial infarction in diabetic 
subjects is similar to a non diabetic with prior myocardial infarction. 
 In a study conducted in Iranian population(31) ,the incidence of 
acute MI has been reported to be higher in diabetic individuals (36.4%) 
than in those individuals without diabetes(19.2%, p value less than 
0.005). 
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 Diabetic subjects with Ml had greater Blood sugar (274.7 ± 130.8 
vs. 216 ± 89.6 mg/dl, p value less than 0.005), Fasting glucose level 
(222 ± 109.3 vs.167.3 ± 75.6 mg/dl, p  value less than 0.01) & HBA1C 
(10 ± 2.4 vs. 9.1 ± 3%, p value less than 0.05) than diabetics having 
unstable angina. They showed that diabetics having inadequate glycemic 
management which was proved by elevated glycated haemoglobin value 
& /or increased plasma glucose & fasting sugar value had greater 
incidence of  Ml. 
GENDER DIFFERENCE IN PROGNOSIS OF ACS IN DM 
Galcera-Tomas(32) studied gender difference in prognosis of acute 
myocardial infarction in diabetes. They showed that females with DM 
suffered a greater incidence of cardiac complications during 
hospitalization when compared to males with DM. Early incidence of 
cardiac failure (in diabetic female vs males with DM ) was 11.7 
percentage versus 4.5 percentage ( resulting in a P value less than 0.01), 
in-hospital incidence rate being 29.6 percentage versus 10.3 percentage 
(giving a p value of 0.001) & one year rate was 42.7 percentage versus 
21.1 percentage ( resulting in a P value  which is greater than 0.001). 
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COMPLICATIONS OF ACUTE CORONARY SYNDROME 
Complications of ACS include conduction disturbances, mechanical 
complications, cardiogenic shock and several other complications. 
• Arrhythmias :  
1. Ventricular premature beat 
2. Ventricular tachycardia/fibrillation 
3. Accelerated idioventricular rhythm 
4. Supraventricular arrhythmias 
5. Sinus bradycardia 
6. Atrioventricular conduction disturbances 
7. Asystole 
• Mechanical complications including  free wall rupture, VSD, MR 
• Hypotension, Left ventricular Failure, Acute Pulmonary oedema, 
Cardiogenic shock 
• Recurrent Myocardial Infarction 
• Pericarditis, pericardial effusion 
• Cerebrovascular Accident  and thromboembolism 
• Left ventricular aneurysm 
• Dressler's Syndrome. 
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MORTALITY OF ACS IN DIABETES MELLITUS 
 Myocardial infarction in type 2 DM has poor prognosis. There is a 
greater occurrence of heart failure, in-hospital adverse effects, atrial 
fibrillation, conduction abnormalities & post-infarction angina. The 
higher mortality among diabetics is related to an increased occurrence of 
left ventricular failure.(33) 
 Lorente (34) analyzed two hundred & thrty five individuals ( of 
which 51.06 percentage were men) with ACS ,DM was found in  26.38 
percentage.Individuals with DM had greater incidence of LVF  (incidence 
being 67.74 percentage versus 53.17 percentage) &  cardiogenic shock 
(incidence being 46.77 percentage versus 32.36percentage)  
 Herlitz(35) studied the mortality, adverse effects & consequences 
of MI, death pattern & the occurrence of recurrent MI for a duration of 
five years following ACS in individuals with & without DM. Individuals 
with DM suffered a 5-year mortality of 72% ,when it was 50% for those 
with out DM  (resulting P value is less than 0.001).  Among diabetic 
patients, 55% developed a re-infarction versus 22% in non-diabetic 
patients (p < 0.001). 
 Paris Prospective Study(12) followed 7018 men aged 44-55years 
up to 23 years & found that  fasting as well as post prandial levels of 
insulin have an association with all-cause mortality & the trend showing a 
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U shaped pattern. The study also proved that those subjects with 
decreased as well as increased levels of insulin have enhanced incidence 
of ACS , independently of other risk parameters.It was observed that 
those individuals having increased levels of  insulin had a greater 
propensity for developing  CAD. 
HbAlC or GLYCATED HAEMOGLOBIN LEVELS 
Glycated or glycosylated haemoglobin (HbA1c) which is 
quantified mainly to find out the average plasma glucose level in the past 
2 to 3 months.It gives an idea about the chronic glucose control of the 
subject.The mechanism of nonenzymatic glycation of Hb is involved in 
its formation.It is formed in a non-enzymatic glycation mechanism by Hb 
being  exposed to plasma sugar.  
When the value of blood glucose is with in the reference range,the 
level of HBA1C also tends to be within the normal limits. With the rise in 
the mean level of blood glucose, the quantitiy of HBA1C also tends to 
rise simultaneously. Hence it function as a marker for average plasma 
sugar values during the past two to three months before the investigation. 
  HBA1C ≥ 48 mmol/mol (≥6.5%) is added in the criteria which has 
been followed to make a diagnosis of DM. 
Elevated levels of HBA1C, suggesting inadequate plasma sugar 
control, is related with development of various cardiac disease. 
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UNDERLYING PRINCIPLE 
Normally, red blood cells have a lifespan of approximately one 
hundred and twenty days. People having improperly controlled DM, 
show a significantly elevated levels of HBA1C when compared to the 
normal subjects.  
When the Hb molecule gets glycated, its a permanent phenomenon. 
Glycated haemoglobin persists in the same pattern till that red blood cell 
finishes its life span. Hence the glycated Hb inside RBC, infact, shows 
the mean value of plasma sugar to which RBC gets exposed in its 
lifespan. Analysing the value of HBA1C is an indicator of successive 
treatment through the monitoring of long-term blood sugar control. 
HbA1c  value corresponds to the mean blood sugar level of the body in 
the prior 4weeks to 3months.But few research workers have the opinion 
that the greater part of HbA1c assay corresponds to the glycaemic control 
of the past fourteen to twenty eight days.  
MEASURING HBA1C 
Several methods have been employed to quantify HbA1c assay.Those 
methods include:  
• High-performance liquid chromatography -In this method 
glycated haemoglobin value is found out as proportion to 
complete Hb in the body. 
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The other methods consist of  
• Immunoassay process 
•  Enzymatic method and 
•  Capillary Electrophoresis 
Diabetes presents with microvascular as well macrovascular 
pathology. Infact disorders pertaining to  macrovascular pathology will be 
occurring even before a clinical diagnosis of DM has made. 
Hyperglycemia itself could be considered as a risk factor in the 
development of CVD. Elevated blood sugar enhances the atherosclerosis 
process through the production of glycated proteins. There is also 
production of advanced glycation end products in the body which is a 
result of elevated blood sugar. They both will result in the worsening of 
endothelial dysfunction . 
Glycosylated Hb can be regarded as a marker of glycated proteins. 
The various land mark studies have considered  the value of HbA1c as an 
indicator of adequate glucose management.  Observations made in 
Framingham study led to the conclusion that there is a 2fold rise in 
cardiovascular mortality among males with DM & a 4fold rise in female 
having diabetes than their corresponding counter-parts without DM.  
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A profound rise in cardiac adverse incidents and mortality have 
been noticed when HBA1C level is above 7%. The above mentioned 
assosciation between raised glycosylated Hb value & elevated 
cardiovascular adverse events is found itself prior to the establishment of 
clinical DM . 
HbAlC LEVELS AND ACS 
 In poorly controlled diabetes, as indicated by glycosylated Hb 
value more than seven percentage, adverse incidents like cardiac failure 
& reinfaction have been observed. 
  Substantially greater proportion of individuals having improper 
glucose management indicated by the glycated Hb value more than seven 
percentage, showed an higher incidence of Unstable angina, ST EMI, 
CCF, severely elevated blood pressure, triple vessel diseases & dilated 
cardiomyopathy .(36) 
Findings of UKPDS study pointed that adequate management of 
blood sugar ( indicated by glycated Hb levels < 7% ) brought a fall in rate 
of MI by sixteen percentage.  However, association made in this study 
had not been proved statistically significant. 
 Mahmut Cakmak (37) studied 100 individuals having ACS and 
measured blood glucose and glycosylated Hb value within three hours of 
hospitalization. Subjects have been categorized in to 3sets based on their 
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glycated Hb value.Those categories consist of glycosylated Hb ranging 
between 4.5percentage and 6.4percentage(number of individuals were25) 
6.5percentage and 8.5percentage (number of individuals were28)   & the 
third set included those values which were greater than 
8.5percentage(number of individuals were25. After that entire individuals 
were subjected to do exercise & imaging studies including the 
angiography of coronary arteries for the assessment of ischemic scores. A 
statistically proven association had been made out between glycated 
haemoglobin value at the time of hospitalization & mortality rates. This 
association resulted in a p value which is equivalent to 0.009. 
Apart from this, a statistically proven assosciation had been also 
established  between elevated glucose value & HBA1C level & complete 
ischemic scores among the individuals having ACS (resultant P value is 
equivalent to 0.001).  
HYPERGLYCEMIA IN ACS 
 Elevated blood sugar level in individuals who were suffering from 
ACS increases the incidence of adverse cardiac events & deaths 
irrespective of their previous glycemic status.  
 Stress induced temporary elevation of blood sugar level has been 
observed in people with out diabetes also.This phenomenon has been 
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related with several complications which occurs in people with  &without 
diabetes. 
PATHOPHYSIOLOGY OF COMPLICATIONS ASSOCIATED 
WITH STRESS HYPERGLYCEMIA 
 
The pathophysiology of these complications are linked to the 
occurrence of enhanced oxidative injury, inflammatory process & 
activation of various enzymes that are known as stress responsive 
kinases.(38) There is a sudden  increase in oxidative stress and 
exaggerated  inflammation due to oscillating hyperglycemia. 
  Other adverse effects of sudden rise in blood sugar include 
accelerated rate of apoptosis, abnormalities of endothelial function as 
well as microcirculation,increased stimulation of coagulation & 
aggregation of platelets .A positive relationship between hyperglycemia 
during hospitalization & further complications of ACS had been observed 
in several studies.(39)  
Acute hyperglycemia has an independent correlation between the 
dysfunction of left ventricle & an extensive infarct area which has 
resulted from a higher rate of no-reflow mechanism(40,41).Infact 
research activities conducted in animals proved that sudden 
hyperglycemia diminishes  the ischemic pre-conditioning.(42)  It has 
been also noted that cardiac activity & function have been impaired in 
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people having elevated blood sugar level along with the development of 
acute MI.(43) 
Acute hyperglycemia leads to a  decrease in  half-life  of fibrinogen 
apart from causing a rise in levels of fibrinopeptideA, prothrombin, factor 
VIII, suggesting increased activation of thrombosis. 
Thus stress induced sudden elevation of blood sugar level has been 
observed to be related with inflammation & various other immune 
reactions. These had resulted in a poor cardiac status & outcome(44). 
Research works have proved that an increased cardiac adverse 
events & related deaths have been found among acute MI individuals 
having hyperglycemia on hospital admission irrespective of their prior 
diabetic status.  
In a study by Petursson 2006 (45) of the one thousand nine hundred 
and fifty seven subjects,twenty two percentage gave a diabetic history. 
In individuals who were not suffering from DM, hyperglycemia at 
admission vs normal sugar levels had greater incidence of thirtyday 
mortality (the incidence being 20.2 percentage versus 3.5 percentage 
which results in a P value of less than 0.0001) .There was also a greater 
incidence of late mortality (19.1 percentage versus 11.7 percentage 
resulting in a  P value that is equivalent to 0.007). 
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 The 30-day mortality rate was significantly greater in hyperglycemia 
at admission without diabetics compared to normoglycemic individuals 
having diabetes resulting in a P value of  0.002. 
ACUTE HYPERGLYCEMIA IN ACS (STRESS HYPERGLYCEMIA) 
Hyperglycaemia is often seen in the initial stage of ACS.  This 
transient elevation of blood sugar has been regarded to have association 
with stress. Individuals having stress related elevation of blood sugar 
value constitute a separate group having a different course of acute 
coronary syndrome when compared with those having normal blood 
glucose level. HbA1c assay serves to differentiate pre-existing DM from 
that of stress induced elevated blood sugar level. 
In patients with acute coronary syndrome, a correlation is drawn 
between increased blood sugar value at the time of hospitalisation & 
incidence of complications. In fact this was not dependent on the prior 
glycemic status. Hence, elevated blood sugar itself would probably lead 
to adverse events in both DM & non DM subjects. 
A controversy has been there whether this elevated blood sugar 
level is a short term phenomenon or an indicator of underlying diabetic 
status.  At the time of hospitalisation, this sudden rise in plasma glucose 
concentration could be an indicator of severely damaged myocardium. 
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However, this stress hyperglycemia is causally associated with 
subsequent worsening of LV function following reperfusion. 
  For several years, intolerance of carbohydrates in ACS was 
subjected to analysis by many researchers. Levine (46) related CAD & 
DM long back itself (even in 1922 itself) .His observation was CAD 
independently results in a state of glycosuria which might not have any 
relation with DM. 
 Raab and Rabinowitz (47) stated that increased blood sugar value 
has been a persistent aasosciation of ACS rather than a condition which is 
related to overt DM. It had been proposed that this might be the result of 
derangement in the vegetative areas of human cerebrum .This work was 
carried out in 1936.Ellenberg,  Osserman &Pollack (48) suggested a 
Novel description of elevated blood sugar level in acute coronary 
syndrome  subjects without DM .They suggested that hyperglycaemia 
could be an indicator of shock. Also it has been considered that increase 
plasma sugar would be related to enhanced occurrence of abnormalities in 
conduction as well as rhythm disturbances. This work was carried out in 
1952. 
Goldberger (49) showed that few individuals with deranged 
glycemic metabolism at the time of ACS had a tendency to develop DM 
in future.( This study was in 1962). In 1967,Datey and Nanda (50) 
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observed that 14 percentage of ACS subjects with dysregulated blood 
sugar level at the time of acute MI had clinical DM in the subsequent 
years.  
Both Taylor et al., & Allison and Hinton (51)gave a probable 
mechanism for the dysregulation of glucose metabolism occurring in 
cardiogenic shocks.The underlying pathophysiology was related to 
defective insulin production ( this work was in 1969). Taylor et al., 
suggested that production of insulin on  IV tolbutamide infusion seems to 
be supressed in shock that was complicating an acute MI.(52)  
Opie, in1971, found that metabolic consequences of ACS have 
been resembled to those observed in any other condition of acute 
stress.(53) 
 Mak et al., have observed that subjects without DM  having 
elevated admission blood glucose value after the first AMI suffered poor 
immediate outcome. (54) It was shown that the non-diabetics with an 
elevated admission plasma sugar value have an increased rate of mortality 
when compared to the diabetics. This might be due to the fact that it is the 
acute fluctuation of blood glucose that results in accelerated inflammation 
and increased oxidative stress. Since the blood sugar value of  diabetics is 
already in a higher range, threshold glucose value to cause the various 
deleterious effects would have been enhanced. The paradoxical resistance 
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of diabetic heart to ischemic challenge could be yet another probable 
reason. In a diabetic heart the activity of sodium-proton (Na-H+) 
exchanger as well as uptake of calcium which carry a significant 
prominence in reperfusion injury have been decreased. Besides, in DM 
there is a fall in the glycolytic mechanism which results in decreased 
accumulation of protons inside the cell. Infact, this could be advantageous 
to heart particularly in conditions of elevated blood glucose level. 
MECHANISM OF STRESS HYPERGLYCEMIA  
ACS can be considered as an example of acute stress involving 
both body & mind. Sudden rise in plasma glucose can be due to increased 
release of  stress hormones, relative decrease of insulin  with increased 
quantity of free fatty acids (FFA). 
Parameters resulting in carbohydrate dysregulation tend to be 
similar to other parameters that increase serum  FFA. Hence this 
demonstrates an intimate association between glucose and FFA 
metabolism in ACS. 
ROLE OF CATECHOLAMINES 
Elevation in glycemic value has been the result of increase in stress 
hormones which include catecholamines & cortisol. Apart from the above 
mentioned ones, an increase in glucagon & growth hormone have also 
been invariably noticed.  
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Due to the activation of human body’s sympathetic pathway, 
elevated catecholamine production occurs. This leads to enhanced 
glucose formation by liver through various mechanism which includes 
not only gluconeogenesis, but also glycogenolysis & ultimately resulting 
in stress hyperglycaemia. Catecholamines have a potential to inhibit the 
insulin production of pancreatic tissues. Thus resulting in low usage of 
blood sugar by muscle & adipose cell. 
CATECHOLAMINES 
In Acute MI, elevated catecholamine secretion happens due to 
sympathetic stimulation, that can be local or general. The 3 cardiac 
associated incidents which can result in enhanced sympathetic 
stimulation consist of the following  
1)  Fear &pain of ACS. 
2)  Hypoxia as well as hypotension which might take place in ACS by 
activation of neurons in vasculature. 
3)  Local destruction of cardiac vascular neurons which are present in 
the infracted heart muscle 
GLUCAGON 
Glucagon’s role in the initial hours of acute MI is not well studied. 
Hyperglycaemia, per se will not result in raised blood glucagon value in 
DM unless insulin deficiency has been present. 
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ELEVATED FFA LEVELS 
Besides glucose dysregulation, elevated catecholamine action 
results in various metabolic derangements such as increase in triacyl 
glycerols, lipolysis & high plasma FFA in ACS. FFA value will be  
elevated within thirty minutes of ACS. 
HbA1c LEVEL VS ACUTE HYPERGLYCIEMA IN ACS 
In a study measuring blood sugar as well as glycated haemoglobin 
level on hospitalization among 521 subjects with MI.(55) Blood sugar has 
been grouped in to those less than 7.8mmol/l with sample number being 
305, those between 7.8 &11.0 with sample number being 138 or those 
greater than 11.1 mmol/l with sample number being 78. HbA1c has been 
categorized in to those less than 6.2 percentage with 420 as sample 
number or those greater than 6.2 percentage with sample number being 
101.  
Mean follow-up period had been 1.6+/-0.5 years. In ACS patients, 
mortality by glucose category had been shown to be 9%, 8% & 25%, 
respectively (p=0.001); mortality by HBA1C category was 10% vs. 17%, 
respectively with a resultant P value which is equivalent to 0.14. 
 Multivariate interpretation showed that glucose category had been 
strongly related with mortality but HbA1c group was not. Thus increased 
admission blood sugar seems to be more significant when compared to 
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previous long-term deranged glucose metabolism in predicting mortality 
of MI subjects. 
Thus admission hyperglycemia can be considered as a significant 
risk factor for mortality in ACS people .No doubt that Diabetic control 
appears to delay the development of ACS.Its effective control along with 
the control of the other risk factors like hypertension, dislipedimia, 
smoking cessation has more benefit. Uncontrolled diabetes, as indicated 
by high HbA1c levels, has poor outcome in ACS & admission 
hyperglycemia appears to have still more grave prognosis. 
. 
 
  
 
 
AIMS AND 
OBJECTIVES 
 36 
AIMS AND OBJECTIVES 
AIM 
To assess the prognosis of patients with ACS comparing admission 
blood sugar and HbA1c values. 
OBJECTIVES 
• To find the blood sugar and HbAIc values at the time of admission in 
ACS patients. 
• To compare the blood sugar and HbA1c values in diabetic and non 
diabetic patients. 
• To determine the age, sex difference in the blood sugar and HbA1c 
values. 
• To find the type of ACS, the adverse cardiac events and condition of the 
patients at discharge. 
• To compare blood sugar and HbA1c values with the patients outcome. 
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MATERIALS AND METHODS 
 The study was conducted at the KAPV Government Medical 
College, Trichy, Tamilnadu. Patients who were admitted in the general 
wards and intensive coronary care unit of Mahatma Gandhi Memorial 
Government Hospital, Trichy with ACS were taken as the study sample. 
 In this study, we recruited 101 patients with acute MI  admitted 
consequently between May 2011 to November 2012 in MGM 
Government Hospital, Trichy. The study included ACS patients with or 
without type 2 diabetes mellitus. 
 The study protocol was approved by institute's ethical committee. 
Informed consent was taken from both patient and caretakers.  
INCLUSION CRITERIA 
 Acute coronary Syndrome diagnosed in patients presenting with 
chest pain and or dyspnoea for >30 minutes and not more than 24 hours 
with ECG changes 
 They were classified into 
 1. STEMI - ST segment elevation 1mm or more in two or more 
contiguous leads with reciprocal ST depression in contralateral leads. ST 
elevation of 1mm in inferior leads and 2 mm in anterior leads is taken as 
significant. 
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 2. Non-STEMI - ST deviation in the ECG along with elevation of 
cardiac biomarkers. 
 3. Unstable angina- ST deviation in ECG without elevation of 
cardiac biomarkers. A diagnosis of Acute coronary syndrome was 
established based on clinical features, above ECG findings and cardiac 
enzyme (CPK) value. 
EXCLUSION CRITERIA 
  Other factors that determine the prognosis of the ACS were excluded 
1. Age >75years, 
2. Pre-existing renal disease 
3. Concurrent systemic infections 
4. Past history of ACS and cardiac events 
5. Past history of Cerebrovascular accidents 
The resident trainee, collected history from the patient and 
responsible caretakers, detailed physical and systemic examination was 
carried out. 
Following clinical evaluation, ECG was taken and blood was sent 
for cardiac markers, blood sugar, and HblAc levels.Admission day 
glycemic status was assessed by sending the blood sample for random 
blood sugar value and HBA1C level at the time of hospital admission. 
 39 
Based on the admission blood sugar level patients were categorized in to 
2 groups with those having RBS < 140mg/dl & those with RBS ≥ 
140mg/dl.A value of 140mg/dl has been taken as cut-off value in 
accordance with American Heart Association(AHA)(46) 
Based on the admission HbA1c level patients are grouped in to 2 
category with those having HbA1c less than 6.5% & those with value 
more than or equal to 6.5%. Routine blood investigations including 
complete haemogram, renal function test, clotting time and bleeding time 
were done.  
Clinically diagnosis of DM was made if the patient is informed of 
the diagnosis by a physician prior to the admission or if he was on any 
therapy for diabetes. ECG has been taken as soon as the patient is 
admitted & also repeated when indicated. ECHO was done on subsequent 
day or at the time of discharge.  
Cardiaovascular  assessment was carried out daily or frequently if 
required as in complicated cases.The diagnosis, ECG, ECHO reports 
were discussed with the treating cardiologist or the physician. The 
findings were recorded in the study proforma. Cases were kept under the 
close follow up till discharge. 
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 Prognosis of patients was assessed by the condition at discharge 
and or ECHO findings at discharge. 
 
DATA ANALYSIS 
Analysis of data done using SPSS 11. 
Independent ‘t’ test, chi square test were used for comparison of data 
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OBSERVATIONS AND RESULTS 
Hundred and one (N=101) patients satisfying the inclusion criteria 
were assessed 
 
DISTRIBUTION OF PATIENTS BASED ON AGE, SEX AND 
DURATION OF HOSPITAL STAY 
Age:      26-74 Yrs,  
Mean Age 57.6 yrs, SD =10.1 
Sex:      Male =77,  Female =24 
Duration of Hospital stay:  2-14 days, mean 8 days 
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Table 1: DISTRIBUTION OF PATIENTS BASED ON THEIR 
Diabetic history 
Known Diabetics 53 
Durations of 
diabetes 
0-25 Years : 
Median =3.87 yrs ;  
SD=5.8 
Treated diabetes Regularly 48 Irregularly 5 
Mode of treatment Oral hypoglycemic agents (OHA) = 43, Inslulin=9 
HBA1C level Ranges = 4.8-10.2  Mean=7.540 
 
Target organ 
damage: 
Retinopathy    2 
Peripheral vascular disease 3 
Pervious Cardiac Events  0 
Acute DM complications  2 
Cerebrovascular damage  1 
Up to 50% of the patients has known diabetes and majority of them were 
treated with oral hypoglycemic agents. 
 The mean HbA1c levels among the Diabetics were 7.540 
indicating a poor control prior to ACS 
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Table 2: Clinical findings in Acute Coronary      syndrome 
 
47%  of patients had 3 or more risk factors for ACS 
 
Risk factors for MI Hypertension    63 
Dyslipidemia   78 
Smoking    38 
Alcohol    33 
Obesity    25 
Life Stress    14 
Post menopausal    21 
Family history of CAD   4  
Chest pain duration Mean=14 hrs   SD=10 Hours 
Dyspnoea 6 patients presented with dyspnoea alone 
Heart rate (/min) 40-150 Mean = 85.7 SD=19.2 
Systolic BP  
Diastolic BP  
150-220 Mean=135.5 SD=28.6 
0-120  Mean=87.1   SD=19.4 
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Table 3: Investigations 
Cardiac enzymes: CPK Positive =52 
Renal Functions testes 
 Blood urea 
 Serum creatinine 
 
 12-49 
 0.6-1.5 
Haemogram: 
 Hb% 
 PCV 
 Total leukocyte count 
 Platelets 
 CT 
 BT 
 
 9-18 
 25-51 
 4000-15800 
 1.6-5 lakhs 
 7-10 min 
 2-4 min 
 
 The table shows that the renal functions test, and routine 
haemogram, and bleeding parameters were in normal limits, the high total 
leukocyte count is expected in ACS 
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Table 4: Admission RBS and HbA1c 
Admission Day Random 
blood sugar  (RBS) 
N=101    Range=66-592mg% 
Mean=220.7 mg% Sd=114.1 
Admission  RBS≥140mg% N=72         Mean = 265.6mg% 
44 were known diabetic (mean = 287.1mg%). 
28 were non-Diabetic (mean=231.9mg%) 
Admission  RBS<140 mg% N=29  Mean=109.3mg% 
9 were known diabetic (mean=116mg%) 
20 were non diabetic (mean = 106.3mg%) 
Admission HbA1c N=101 Range=4.7-11.0 Mean=6.8, SD=1.51 
Admission HbA1c ≥ 6.5 N=59          Mean = 7.89 
45 were diabetic (mean=7.89) 
14 were non diabetic (mean=7.65) 
Admission HbA1c < 6.5 N=42          Mean = 5.5 
8 were known diabetic (mean=5.57) 
34 were non diabetic (mean=5.48) 
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Table 4A: RBS, HbA1c in Diabetic and Non Diabetic patients 
 
  N Mean Std Deviation 
Std. 
Error 
Mean 
P 
value 
RBS Non DM 
DM 
48 
53 
178.49 
260.65 
93.506 
118.226 
13.358 
16.395 
.0001 
.0001 
HbA1c Non DM 
DM 
48 
53 
6.151 
7.540 
1.3523 
1.3590 
.1932 
.1885 
.0001 
.0001 
 
 The blood sugar among the diabetics had high admission RBS and 
HbA1c values when compared to the non-diabetics presenting with Acute 
coronary syndrome 
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DiagnosIs 
 
 
 
 
 
 
 
 
 
 
 
Unstable angina
19%
non STEMI 
35%
STEMI 
46%
 48 
Adverse Cardiac Events (ACE) 
 
 
 
 
 
 
 
 
NIL 
56% 
Cardiogenic Shock 
5% 
Arrhythmias 14% 
Acute LVF 25%
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CARDIAC OUTCOME 
 
 
 
 
 
 
 
 
Reasons for Death : 
  Acute left ventricular failure,  
Cardiogenic shock  and  
Ventricular arrhythmias. 
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Table 5: Admission blood sugar, HbA1c and Condition at discharge 
 
  N Mean Std Deviation 
Std. 
Error 
Mean 
P 
value 
RBS Recovered 
Poor outcome 
87 
14 
219.29 
230.14 
119.442 
75.708 
12.806 
20.234 
.743 
.654 
HbA1c Recovered 
Poor outcome 
87 
14 
6.844 
7.007 
1.532 
1.475 
.1643 
.3943 
.711 
.706 
 
 87 had recovered satisfactorily, 14 had residual dysfunction or 
death. There was no statistical difference in admission RBS or HbA1c 
with respect to condition at discharge. 
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Table 6: Admission blood sugar, HbA1c and Adverse cardiac Events 
(ACE) 
 
  N Mean Std Deviation 
Std. 
Error 
Mean 
P 
value 
RBS ACE absent 
ACE present 
57 
44 
179.82 
273.86 
82.52 
127.76 
10.93 
19.26 
.0001 
.0001 
HbA1c ACE absent 
ACE present 
57 
44 
6.747 
7.020 
1.59 
1.42 
0.21 
0.21 
.37 
.36 
 
 Adverse cardiac events (ACE) were found in 44 patients 
 Admission RBS were significantly high in patients with adverse 
cardiac events while HbA1c was not 
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Table 7 A: Diabetic patients and Adverse cardiac events with 
ADMISSION RBS VALUE 
 
RBS ACE Present ACE absent Total 
<140mg % 2 7 9 
≥140mg % 21 23 44 
Total 23 30 53 
 
Chi square test (χ2) = 3.066 Degree of freedom (df)=1 
P>0.05 Null hypothesis is true 
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Table 7B: diabetic patients and adverse cardiac events with 
ADMISSION HbA1c VALUE 
 
 ACE Present ACE absent Total 
HbA1c<6.5 3 5 8 
HbA1c≥6.5 20 25 45 
Total 23 30 53 
 
Chi square test (χ2)=0.1335 Degree of freedom (df)=1 
p>0.5 Null hypothesis is true 
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Table 7C: Non-Diabetic patients and Adverse cardiac events 
 
 ACE Present ACE absent Total 
<140mg% 4 16 20 
≥140mg 17 11 28 
Total 21 27 48 
 
Chi square test (χ2) = 7.84 Degree of freedom (df)=1 
P > 0.005 Null hypothesis is true 
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Table 7D: Non-Diabetic  patients and Adverse cardiac events with 
HbA1c 
 
 ACE Present ACE absent Total 
HbA1c<6.5 14 20 34 
HbA1c≥6.5 7 7 14 
Total 21 27 48 
 
Chi square test (χ2) = 0.313 Degree of freedom (df)=1 
p>0.5 Null hypothesis is true 
The above four tables (7A, 7B, 7C, 7D) shows that patients with no 
history of diabetic when presented with admission RBS ≥ 140mg% has 
significant adverse cardiac events. While HbA1c values did not predict 
adverse cardiac events both in diabetic and diabetic patients 
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Table 8: Mean age difference among DM & non DM 
 
  
Mean age 
(years) 
Std 
Deviation 
Std. Error 
Mean P.Value 
Non DM 48 56.08 12.261 1.752 .141 
Age 
DM 53 59.08 7.590 1.052 .147 
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Table 8A: Age of patients AND cardiac out come 
 N 
Age 
mean 
(Yrs) 
Std 
Deviation 
Std. 
Error 
mean 
P.value 
ACE absent 57 56.25 10.029 1.328 .122 
ACE present 44 59.41 10.228 1.542 .124 
Recovered 87 57.56 10.438 1.119 .883 
Age 
Poor outcome 14 85.00 8.840 2.363 .869 
 
 There were no statistical difference between the age of Diabetic 
patients compared to non diabetic patients. 
 The patient’s age was not statistically significant with the adverse 
cardiac outcome (ACE) or the condition of discharge. 
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Table 9: Gender difference IN admission RBS and HbA1c VALUES 
  N Mean Std Deviation 
Std. 
Error 
mean 
P value 
Male 77 218.27 110.95 12.64 .693 
RBS 
Female 24 228.88 126.01 25.72 .714 
Male 77 6.88 1.476 .168 .844 
HbA1c 
Female 24 6.81 1.678 .342 .854 
 
 There was no gender difference in admission RBS and HBA1C 
values in patients presenting with ACS 
 59 
Table 9A: Gender difference and  
Adverse Cardiac Events (ACE) 
 
 
ACE Present ACE absent Total 
Male 32 45 77 
Female 12 12 24 
 Total 44 57 101 
 
 Chi square test (X2) = 0.515 Degree of freedom (df) =1 
 P>0.05 Null hypothesis is true 
 There were no gender difference with respect to adverse cardiac 
events. 
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Table 10A: duration of Diabetes and ACE 
 N Mean (years) 
Std 
Deviation 
Std. 
Error 
Mean 
P Value 
ACE 
absent 
57 3.29 5.260 .697 .262 Duration 
of DM 
ACE 
present 
44 4.61 6.535 .985 .276 
 
Duration of diabetes were unrelated to the adverse cardiac outcome 
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Table 10B:  Duration of hospitalization and Adverse Cardiac Events 
(ACE) 
 
 N Mean  Std Deviation 
Std. 
Error 
Mean 
P Value 
ACE 
absent 
57 7.95 1.216 .161 .001 Duration 
of DM 
ACE 
present 
44 9.23 2.381 .359 .002 
 
Patients with adverse cardiac events were hospitalized for longer duration 
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DISCUSSION 
THE STUDY SAMPLE: 
 Our study population included only patients admitted with ACS 
with or without history of type 2 Diabetes. 
 Comorbidities such as renal disease, Cerebrovascular accident, 
previous history of Ml concurrent infections were excluded, so as to study 
the prognosis related to the diabetes and blood sugar alone. 
DIABETIC HISTORY 
 Diabetes comprised just above 50% of the sample (N=53) and 
majority of them (81 %) were treated with oral hypoglycemic agents. 
Complications related to Diabetes comprised less than 5%.Mean HbA1c 
among diabetics was 7.54% indicating a poor control prior to diabetes. 
This high value of HbA1c also indicates that though majority of the 
diabetics have received some treatment with either oral hypoglycemic 
agents or insulin, the treatment was not adequate. This may be either due 
to lack of compliance or improper follow up. 
CLINICAL FINDINGS IN ACS 
 Apart from diabetes upto 47% of the patients had 3 or more risk 
factors for ACS, majority of them being hypertension, dyslipidemia, and 
smoking. Other risk factors observed in our study include obesity, life 
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stress, post menopausal state and family history of diabetes. Similar 
observations were noted in several other studies which have proven that 
hypertension and dislipidemia are more frequent comorbidities in 
diabetics.(3) 
THE BLOOD SUGAR VALUES 
ADMISSION RBS AND HbA1c 
Random blood sugar values measured in our study population fell 
in the range of 66mg% to 592mg%.In our study,72 patients had 
admission RBS ≥ 140mg/dl. Among this 44 patients were known 
diabetics.That means 71% of the study population presented with acute 
hyperglycemia irrespective of their diabetic status. And among the 
hyperglycemia group 61% were having previous history of diabetes. Only 
nearly 29% patients presented with an admission RBS value <140mg/dl 
which clearly shows that in patients with ACS there is a high incidence of 
elevated admission plasma glucose value. 
In this study, 59 patients had admission HbA1c value ≥6.5, of 
which majority, ie 45 patients (more than 76%) were known case of 
diabetes. Fourteen patients without a previous history of diabetes showed 
an elevated admission HbA1c value. These patients might be suffering 
from diabetes as indicated by an elevated glycated Hb value which was 
undiagnosed so far. 
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ADMISSION RBS & HbA1c IN DIABETIC AND NON DIABETIC 
POPULATION 
 
 The mean blood sugar among the diabetes was 260.65 mg% and non 
diabetes 178.49 mg% 
 The mean HbA1c among the diabetes was 7.54 and non diabetes 
6.15, the difference was statistically significant.From these it is evident 
that the diabetic population had both high admission RBS and poor 
control prior to ACS. 
 This is in concurrence with earlier study by Esteghamati(31) found 
myocardial infarction was more frequent in diabetic patients compared to 
non diabetic patients. 
 Diabetic patients with Ml had significantly higher blood sugar, and 
HBA1C compared to non diabetics. Also it has been found that the 
occurrence of CAD tends to be decreased in subjects having HbA1c level 
less than 6.5 %.(22). Studies have shown that individuals having higher 
HbA1c value have very high risk of CVD. (56,57) 
ACS AND CLINICAL OUTCOME 
 Our study showed that 46% had ST elevation Ml, 35% non ST 
elevation Ml and 19% had unstable angina. While population based 
studies have shown that up to 23.1% of patients presented with ACS has 
ST elevation Ml. 
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 The common causes of mortality in the diabetics were heart failure, 
atrial fibrillation, conduction abnormalities and post infarction angina. 
 Diabetic patients shows larger infarct size, increased occurrence of 
left ventricular failure. (33) 
 In our patients acute LVF, arrhythmias, cardiogenic shock were 
found in 25,14,5 % respectively of which 6 patients died mainly due to 
Left ventricular failure, ventricular arrhythmias and cardiogenic shock. 
In this study, the most common adverse cardiac event observed 
was left ventricular failure. Several other studies have also made the 
similar observation. Cardiac failure had been very frequently associated 
with increased admission plasma sugar value in MI patients. (58).  
ADMISSION BLOOD SUGAR, HbA1c AND CLINICAL 
OUTCOME 
 
 During discharge from hospital 87 had recovered satisfactorily, 8 
had complications such as residual ventricular dysfunction, AV block, 
ventricular septal rupture, mitral regurgitation and 6 patients had died. 
 There was no statistical difference in mean values of admission 
RBS and HBA1C with respect to the outcome of the patient during 
discharge, probably due to the intervention during the hospital stay. 
In our study the adverse cardiac events such as acute LVF, 
Ventricular arrhythmias, cardiogenic shock were found in 44 patients 
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following ACS; they had longer duration of stay in hospital, and this was 
unrelated to the age and sex of the patients, or duration of diabetes. 
The patients with adverse cardiac events had a mean admission 
RBS& HbA1c of 273.86mg% and 7.020 respectively, while it was 
179.82mg% and 6.747 for those without adverse cardiac events. 
 In this study the mean admission RBS were significantly high in 
patients with adverse cardiac events while mean HbA1c was not. 
Moreover patients presenting with above normal admission RBS 
(≥140mg%), had more adverse cardiac events. This was statistically 
significant in non diabetic patients. 
This study had shown that patients with no history of diabetes 
when presented with an elevated admission RBS have significant adverse 
cardiac events when compared to a diabetic patient with elevated 
admission RBS. 
Similar observation was made in various other studies. In the study 
by Mak et al, it has been shown that subjects without DM  having 
elevated admission blood glucose value after the first AMI suffered poor 
immediate outcome. (54) 
In our study HbA1c values did not predict adverse cardiac events 
both in diabetic and non diabetic patients.  
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Several studies discussed about whether the role of admission 
glucose levels was more important than diabetes history in patients with 
AMI. Goyal A, et al.,. found people having ACS with admission blood 
sugar value of more than 144mg/dl  had an increased rate of mortality 
irrespective of prior diabetic status.(59) Admission glucose levels in non-
diabetic patients with AMI could also offer a good screening tool to 
evaluate the high risk for future type II DM patients.(60) 
Hsu CW, et al.,. also found an increased initial glucose value in the 
emergency department was an independent predictor of short as well as 
long-term adverse prognosis in individuals first MI.(61)  
Individuals with a prolonged history of DM more often have signs 
of diabetic neuropathy which can cause atypical symptoms during MI . 
Hence, diagnosis of MI has become a challenge in such subjects and 
initiation of proper treatment has often prolonged. 
Studies have shown that in individuals having ACS, DM has been 
related with greater mortality rates, both within the hospital as well as 
during long-term follow-up. (62) In fact, this tends to be the pattern in the 
entire ACS category. 
 Elevated plasma sugar value in subjects hospitalised for MI seems 
to be a frequent phenomenon. Studies have pointed out that there is a 
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greater rate of mortality and other complications due to this elevation in 
both group of individuals with & without DM.(63)  
The correlation between enhanced plasma glucose on 
hospitalization & adverse consequences might be the parameter which is 
independent of other prognostic determinants. (64)  
AGE AND SEX DIFFERENCE BETWEEN DIABETICS & NON 
DIABETICS 
 
In our study mean age of diabetic ACS patient was 59 years and 
that of non diabetic was 56 years indicating the absence of a statistically 
significant difference between age of diabetic patients when compared to 
non diabetic patients. 
There were no age and sex preponderance between the diabetic and 
non diabetic population in our study indicating it is a homogenous 
sample. 
GENDER DIFFERENCE IN ADMISSION RBS & HbA1c VALUES 
Of the total population,77 were males & 24 were females. The 
mean RBS value and HbA1c values among males were 218.27mg% and 
6.88% respectively, and that of females were 222.88mg% and 6.81% 
respectively. Our study shows that there is no gender difference in 
admission RBS & HbA1c values in patients presenting with ACS. 
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GENDER DIFFERENCE & ADVERSE CARDIAC EVENTS(ACE) 
In this study, of the total 77 males 32 developed ACE and of the 
total 24 males 12 developed ACE. The present study showed that there 
were no gender differences with respect to adverse cardiac events. 
But epidemiological studies have shown that women have greater 
incidence of  proven DM than males and a increased relative hazard of 
death compared to non diabetic ladies.(4) 
DURATION OF DIABETES & ACE 
Our study showed that duration of diabetes was unrelated to the 
adverse cardiac outcomes. 
DURATION OF HOSPITALIZATION & ACE 
This study shows that patients with ACE had a longer duration of 
stay in hospital. 
Admission hyperglycaemia seems to be a powerful predictor of 
mortality even  in subjects without a diabetic history. Hence admission 
blood sugar value of MI can be taken as an indicator to find out high risk 
subjects so that proper treatment & careful monitoring could be initiated 
very early itself. 
Both HbA1c and admission glucose may have relation with 
adverse prognosis.However,our results suggest that increased admission 
glucose is more important. The less clear association between HbA1 C 
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and prognosis in our analysis could be due to a limited number of patients 
with a relatively short follow-up in our study. 
Limitations of study: 
 The study was limited to the hospital stay only, follow up of these 
patients was not done. 
Long term follow up study is required to evaluate the correlation 
between HbA1c values and outcome of the patients with ACS. 
Large sample size is required to confirm the age, and gender 
difference in ACS outcome. 
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CONCLUSIONS 
The following conclusions could be made out from this study 
• More than 50% of the patients had known diabetes, indicating that the 
diabetic patients have a greater incidence of ACS 
•  Mean HbA1c among diabetics was 7.54% indicating a poor control prior 
to diabetes. This is inspite of the fact that the majority of them were 
treated with oral hypoglycaemic agents. This indicates that the current 
treatment received by the diabetics in our study group is inadequate. 
• The Diabetic patients had high admission RBS value and HbA1c values 
when compared to the non-diabetics presenting with ACS. 
• Adverse cardiac events occurred in nearly 44% of ACS patients 
• The most common adverse cardiac event is acute left ventricular failure. 
 Admission RBS were significantly high in patients with adverse cardiac  
events while HbA1c was not. 
• Patients with no history of diabetes when presented with an elevated 
admission RBS have significant adverse cardiac events 
• Even though high HbA1c values in a diabetic population is a predictor of 
acute coronary syndrome, HbA1c can't be used as a marker to predict 
immediate adverse cardiac events during an ACS in both diabetics &non-
diabetic patients . 
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• There were no age and sex preponderance between the diabetic and non 
diabetic population  
• There was no gender difference in admission RBS & HbA1c values in 
patients presenting with ACS. 
• There were no gender differences with respect to adverse cardiac events. 
• Duration of diabetes was unrelated to the adverse cardiac outcomes. 
• Patients with adverse cardiac events had a longer duration of stay in 
hospital. 
• Admission hyperglycaemia seems to be a powerful predictor of mortality 
even  in subjects without a diabetic history. 
• Uncontrolled diabetes as indicated by high HbA1c values is a strong 
predictor for development of Acute coronary syndrome. 
• However, acute disturbances in glucose levels as indicated by high 
admission RBS appears to be of greater importance in predicting short 
term outcome. 
• Hence admission blood sugar value of MI can be taken as an indicator to 
find out high risk subjects so that proper treatment & careful  monitoring 
could be initiated very early itself. 
  
 
 
 
SUMMARY 
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SUMMARY 
Our study was a prospective study connducted to analyse the 
assosciation between the admission RBS and HbA1c values with the 
outcome of ACS patients during the hospitalization period.Study was 
done in 101 patients which included both diabetics & non-diabetics. 
Of the total patients 53 were type 2 diabetes mellitus. Mean blood 
sugar among diabetics was 260.65mg/dl and non diabetics 178.49 mg/dl 
and mean HbA1c among diabetics was 7.54 and non diabetics 6.15. The 
difference was statistically significant indicating the diabetic population 
had both high RBS and poor control. 
 46% had ST elevation Ml, 35% non ST elevation Ml and 19 had 
unstable angina. Adverse cardiac events such as acute left ventricular 
failure, ventricular arrhythmias and cardiogenic shock were found in 44 
patients. During discharge 87 had recovered satisfactorily, 8 had 
complications such as residual ventricular dysfunction, AV block, 
ventricular septal rupture, and mitral regurgitation. Six patients had died 
due to left ventricular failure and ventricular arrhythmias. 
There were no age and sex preponderance with adverse cardiac 
events, and the duration of diabetes, while these patients had longer 
hospital stay. 
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The mean admission RBS were significantly high in patients with 
adverse cardiac events while HbA1c was not. 
 Also when patients presented with admission RBS ≥140mg% had 
significantly higher adverse cardiac events especially in non diabetic 
patients. 
There was no statistical significant association between HbA1c and 
adverse cardiac events in diabetic as well as non diabetic patients. 
Both HbA1c and admission glucose may have relation with 
adverse outcome. However, our results suggest that increased admission 
glucose is more important. The less clear association between HbA1c and 
prognosis in our analysis could be due to a limited number of patients 
with a relatively short follow-up in our study. 
RECOMMENDATIONS: 
Blood sugar control among diabetics is necessary to prevent ACS. 
Blood sugar control in ACS patients is essential to improve its 
outcome whether the patient had diabetes or not.  
Long term follow up study is required to evaluate the effect of 
uncontrolled diabetes following ACS. 
From this study it is clear that higher admission blood sugar value 
in ACS is a powerful predictor of increased incidence of in-hospital 
adverse events, especially in subjects without prior history of diabetes. 
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Also it is evident that hyperglycemia is very frequent in the setting of 
acute coronary syndrome and mostly this is left untreated. 
Hence acute hyperglycemia in ACS needs early detection and 
prompt management should be carried out inorder to have a better 
outcome.  
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ABBREVIATIONS USED IN THE DISSERTATION 
 
ACS   -  Acute Coronary Syndrome 
AMI   – Acute Myocardial Infaction 
DM   –  Diabetes Mellitus 
CAD   –  Coronary Artery Disease 
CVD   – Cardio Vascular Disease 
STEMI  –  ST Elevation Myocardial Infaction 
NSTEMI  – Non St Elevation Myocardial Infaction 
LVF   – Left Ventricular Failure 
CCF   –  Congestive Cardiac Failure 
ACE   –  Adverse Cardiac Events 
FFA   –  Free Fatty Acids 
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PROFORMA 
STUDY PROFORMA 
Name:        IP NO: 
Age / Sex        DOA 
Diabetes        DOD 
Duration: 
Treatment history ( treated regularly/Irregularly) 
(OHA/Insulion/both) 
Any target organ damage: Retinopathy,nephropathy,CVA,peripheral 
vascular disease 
Any other diabetic complications 
Comorbid conditions ( hypertension,dyslipidemia,obesity,smoking,stress) 
Presenting complaints 
Positive findings. 
Investigations 
Admission RBS  
Admission HBA1C 
 ECG  
ECHO 
Cardiac enzymes 
Urea/creatinine 
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Hb    PCV 
TC    platelet 
CT    BT 
Adverse cardiac events  
 
Condition at discharge 
(recovered /residual dysfunctions / death)  
Diagnosis 
 (ACS STEMI, NSTEMI, Unstable angina) 
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PCV 
67 1 1 8 10 1 3 0 0 0 0 0 0 1 1 1 0 0 0  6 0 92 180 80 1 1 1 346 10.1 St dep anterior leads  no rwma,n lvf 0 33 1.2 13 7500 4 39.6 
46 1 0 7 0 0 0 0 0 0 0 0 0 0 0 1 0 1 0  3 0 84 110 70 1 1 1 203 9.6 st ele inferior leads  hypo rca mild Lvd  0 13 0.8 12.6 10000 2.25 39 
49 2 1 9 7 1 1 0 0 0 0 0 0 1 1 0 0 0 0 pt hysterectomy 10 0 90 150 90 1 1 1 297 8.3 st dep anterior leads hypo Lad n Lvf  0 15 0.8 8.9 10300 2.68 25 
55 1 1 7 5 1 1 0 0 0 0 0 0 0 0 1 1 1 0  22 0 63 120 90 1 1 1 231 8.6 st ele anterior leadfs evolved hypo lad mild Lvd  0 17 1.1 15.4 11200 4.35 44.4 
60 1 1 8 5 1 1 0 0 0 0 0 0 1 1 0 0 0 0  3 0 102 190 120 2 2 1 289 9.4 st dep anterolateral leafs hypo lad severe Lvd  1 24 1.3 17.7 5400 1.2 45 
70 1 1 7 1.5 1 1 0 0 0 0 0 0 1 1 0 0 0 1 post menopause 20 0 75 130 100 1 1 1 164 6.5 lbbb global Lv hypo, severe Lvd  0 17 1.2 13 10400 3 40.6 
65 1 1 9 12 1 1 0 0 0 0 0 0 0 0 0 0 0 0  18 0 114 100 70 1 2 1 339 7.2 st ele anterior leads evolved  global Lv hypo, severe Lvd  1 40 1.4 12.9 17200 2.3 37 
58 2 1 7 6 2 1 0 0 0 0 0 0 1 1 0 1 0 0 post menopause 24 0 76 120 80 1 1 1 147 4.8 st ele anterior leads evolved  hypo lad mod Lvd 1 18 1.2 9.6 10000 4.5 29 
63 1 1 13 3 2 1 0 0 0 0 0 0 0 1 0 0 0 0  20 0 80 136 90 1 1 1 533 8.6 ele anterior leadfs evilved  global Lv hypo, severe Lvd  1 43 1.2 11.7 14200 3.6 34.8 
53 2 1 7 10 2 0 0 0 0 0 0 0 1 1 0 1 0 0 post menopause 4 0 82 150 100 1 2 1 233 9.3 str dep anterior leads  global Lv hypo, severe Lvd  1 36 1 11.3 8200 2.7 35.3 
74 1 0 12 0 0 0 0 0 0 0 0 0 1 1 0 0 0 0  0 4 96 170 110 2 2 1 473 5.6 str dep anterior leads hyo Lad mod Lvd 1 33 1.4 13.5 23800 2.9 41.8 
52 2 1 7 1 1 1 0 0 0 0 0 0 1 1 0 0 0 0 post menopause 6 0 92 160 110 1 1 1 244 8.6 str dep anterior leads hyo Lad mod Lvd 1 12 0.9 13 8300 2 40.2 
63 1 1 10 18 1 1 0 0 0 0 0 0 0 1 1 0 1 0  5 0 116 120 80 1 1 1 406 5.9 st ele anterior leads  hyo Lad mod Lvd 1 34 1 14.4 11500 3.4 43 
50 1 1 2 3 1 1 0 0 0 0 0 0 0 1 0 0 1 0  3 0 100 160 110 2 2 1 219 8 st ele anterior leads  hyo Lad mod Lvd 1 20 1.2 15.3 16800 4.1 44.5 
70 1 1 7 10 1 1 0 0 0 0 0 0 1 1 0 0 0 0  4 0 102 170 110 2 2 1 280 5.9 st ele anteior leads evolved  hyo Lad mod Lvd 1 31 1.3 11.5 15000 1.9 38 
74 1 0 11 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 Bph  0 4 80 170 120 2 2 1 473 5.6  st dep lateral leads hyo Lad mod Lvd 1 33 0.9 13.5 13800 2.4 41 
72 1 0 7 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0  9 0 102 210 100 1 2 1 250 6.3 st dep anterior leads  hyo Lad mod Lvd 0 27 1.2 12.6 13100 3.5 38 
45 2 0 7 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 pt hysterectormy  22 0 80 140 90 1 1 1 100 5.3  st depinferior leads no rwma, n Lvf 0 23 0.9 13.7 9000 4 40 
70 1 0 7 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0  3 0 54 100 70 1 1 1 119 5.5  st ele inferior leads evolved hypo rca, nLvf  1 30 1.1 12.6 13000 3.1 39 
48 1 0 7 0 0 0 0 0 0 0 0 0 1 1 1 1 1 1  4 0 114 130 80 2 1 1 186 6  st ele anterior leads hypo lad,mild Lvd  1 38 1.5 12.6 14200 2.68 36 
41 1 0 7 0 0 0 0 0 0 0 0 0 0 1 1 0 1 0 family h/o cat  5 0 46 160 102 1 1 1 121 5.3  st ele inferior leads evolved hypo rca, n Lvf 1 19 1.1 17.9 16000 3.12 51.7 
66 1 0 7 0 0 0 0 0 0 0 1 0 1 1 0 0 1 0  4 0 96 130 70 1 1 1 138 5.2  st dep inferior leads  hypo rca, n Lvf 1 32 1.4 9.9 8300 3.4 29.6 
62 1 1 9 14 1 1 0 0 0 0 0 0 0 0 1 0 1 1  0 6 60 130 80 2 2 1 369 6.2  st dep anterior leads hypo Lad, mod Lvd 1 43 1 10 9400 1.8 31 
54 1 1 7 1 2 0 0 0 0 0 0 0 1 0 1 0 0 0 family h/o cat  20 0 92 160 100 1 1 1 264 9.6  st dep anteroseptal leads hypo Lad, mod Lvd 1 30 1.2 13.3 9800 2.84 40.2 
68 2 0 7 0 0 0 0 0 0 0 0 0 1 1 0 0 0 0 post menopause 4 0 80 160 110 1 1 1 172 5  st ele lateral leads hypo Lad, mod Lvd 0 41 1.1 13.3 8100 2.34 40.7 
54 1 0 7 0 0 0 0 0 0 0 0 0 0 0 1 1 1 0  2 0 86 130 90 1 1 1 156 6 st ele anterior leads hypo Lad, n Lvf 1 24 1.4 16.5 11500 3.74 48.5 
56 1 1 7 2 1 1 0 0 0 0 0 0 0 1 0 1 0 0  3 0 90 120 80 1 1 1 120 6.7 st ele inferior leads evolved  hypo rca mild Lvd  1 19 1.4 16 13500 2.36 48 
50 1 1 7 5 1 1 0 0 0 0 0 0 1 1 0 0 1 0  1 0 86 140 96 1 1 1 233 8.3  st ele anterior leads  hypo rca mild Lvd  0 16 0.9 14.8 17600 2.6 42.9 
53 1 1 7 1 1 2 0 0 0 0 0 0 1 1 1 0 1 0  5 0 70 120 80 1 1 1 144 5.9  st dep anterior leads  no rwma, n Lvd 0 31 1.3 17.7 12000 4.2 45 
55 1 1 7 1 1 4 0 0 0 0 0 0 0 0 0 0 0 0  4 0 50 100 70 1 1 1 96 5  st ele lateral leads evolved  hypo Lad, mild mod Lvd  0 43 1 15.3 9200 4 39 
65 1 0 7 0 0 0 0 0 0 0 0 0 1 1 0 0 0 0  22 0 80 150 100 1 1 1 198 6.9  st dep anterior leads  hypo Lad, mild  Lvd  1 19 1 12.2 14300 1.97 37.9 
35 1 0 7 0 0 0 0 0 0 0 0 0 0 1 1 1 1 0  4 0 72 120 90 2 1 1 155 6  st ele anterior leads  hypo Lad, mild Lvd  0 16 1 16.8 5700 3 49 
50 1 0 7 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0  4 0 86 120 70 2 2 1 107 5.3  st dep inferior leads  no rwma, n Lvf  0 32 1.2 13.3 6200 3.2 36 
74 1 0 7 0 0 0 0 0 0 0 0 0 1 1 1 1 1 1  10 0 84 110 70 1 1 1 145 5 st ele anterior leads  hypo rca, mild Lvd  0 46 1.3 11.5 8600 2.98 34.8 
70 1 1 7 10 1 1 0 0 0 0 0 0 1 1 0 0 0 1  3 0 60 140 80 1 1 1 148 8.7  st depinferolateral leads  hypo rca, Lcx, mod Lvd  1 35 1.2 12.4 9500 4 35.58 
47 1 1 7 5 2 1 0 0 0 0 0 0 0 1 1 0 0 0  20 0 60 110 70 1 1 1 105 10.2 st dep anterior leads  no rwma, n Lvf  0 33 1.1 14.9 16100 2 42.2 
26 1 0 7 0 0 0 0 0 0 0 0 0 0 1 1 1 1 0  6 0 98 110 70 1 1 1 79 4.9  st ele anterior leads  hypo Lad mod Lvd  0 30 1 14.5 13000 3.6 42.9 
40 1 0 7 0 0 0 0 0 0 0 0 0 1 1 1 1 1 1  6 0 118 110 90 2 2 1 182 9.2 st ele inferior leads evolved  global Lv hypo, severe Lvd  1 29 1.3 13.7 13000 1.87 39.5 
70 1 0 7 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 hypothyroids  1 0 40 96 70 1 1 1 167 5.2  st ele inferior leads  hypo rca, n Lvf 0 20 1.2 12.6 12300 3.43 37 
70 2 1 7 4 1 1 0 0 0 0 0 0 1 1 0 1 0 0 post menopause 0 6 102 180 120 2 2 1 182 6.4  st ele inferior leads evolved  hypo rca,n mild Lvd, mod mr 0 31 1.4 13 17100 2.15 38 
60 1 0 8 0 0 0 0 0 0 0 0 0 0 1 0 0 1 0  10 0 92 140 90 2 2 1 299 7.1  st ele lateral leads  hypo Lad,severe LVD 1 25 1.4 14.8 17100 3.05 45.8 
74 1 1 10 20 1 1 0 0 0 0 0 0 1 1 0 0 0 0  2 0 86 50 0 1 1 1 406 9.3  st ele inferior leads  hypo rca, n lvf 0 26 1.2 11.4 7200 2.39 34.5 
56 1 1 7 5 1 1 0 0 0 0 0 0 1 1 0 1 1 0  7 0 84 110 70 1 1 1 122 7.6  st ele anterior leads evolved  hypo rca, n Lvd 0 15 0.9 13.8 8500 2.27 40.3 
64 1 1 8 6 1 1 0 0 0 0 0 0 1 1 1 1 1 1 family h/o cad  22 0 108 140 80 1 1 1 327 7.2  st eleiferior leads evolved  hypo rca, n Lvd 1 17 1.4 10.2 12500 4 32.6 
54 1 0 7 0 0 0 0 0 0 0 0 0 1 1 0 1 0 0  2 0 80 130 80 1 2 1 185 5.2  st ele anteroseptal leads evolved  hypo Lad mild Lvd  1 30 1.4 14.4 10100 4.2 43 
55 1 0 7 0 0 0 0 0 0 0 0 0 1 1 1 0 1 0  6 0 82 150 90 1 1 1 214 6  st dep anterior leads  hypo rca, mild Lvd  1 23 1 16.4 18800 4 43 
62 1 0 7 0 0 0 0 0 0 0 0 0 1 1 0 0 1   0.5 0 69 140 80 2 1 1 120 6.1  st ele anteroseptal leads evolved  hypo lad, n Lvf 0 48 1.2 9.5 9000 3 31.7 
50 1 1 5 3 1 1 0 0 0 0 0 0 0 1 0 0 0 0  23 0 100 110 60 2 1 1 180 6.3  st ele anterior leads evolved  apical vsr,hypo Lad severe LVD 0 17 1.2 13.5 12300 2.7 40.2 8
72 2 1 8 10 1 1 0 0 0 0 0 1 1 1 0 1 0 0 post menopause  6 0 124 140 80 1 2 1 292 9  LBBB hypo Lad, mild Lvd  1 29 1.5 8.5 6300 2.9 25.5 
56 1 0 77 0 0 0 0 0 0 0 0 0 1 1 0 0 1 0  4.5 0 94 130 80 1 1 1 130 5  st ele anteior leads evolved  hypo Lad, mod - severe LVD  0 19 1.1 14.5 14000 3.2 44.4 
55 2 0 7 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 Post menopause  24 0 82 130 80 1 1 1 82 5  stdep anterior leads  hypo lad, n lvf 1 15 0.9 11.5 13500 3.67 33.7 
64 1 1 7 1 1 1 0 0 0 0 0 0 1 0 0 0 1 1  22 0 66 110 50 1 1 1 109 6.5  st dep inferior leads no rwma , n lvf 1 34 1.4 11 8300 3.89 32.9 
63 1 0 8 0 0 0 0 0 0 0 0 0 0 1 0 0 0 1  3 0 86 140 90 1 1 1 110 5.9  st ele anterior leads  hypo lad servere LVD 0 17 1.3 15 12400 2.45 45 
60 2 1 7 12 1 1 0 0 0 0 0 0 1 1 0 0 0 0  4.5 0 80 150 100 1 1 1 338 8.6  st dep inferior leads  no rwma, n lvf 1 31 1.2 12.8 13400 3.57 38.8 
72 1 0 7 0 0 0 0 0 0 0 0 0 0 1 1 0 1 0  18 0 65 140 90 1 1 1 132 6  st ele inferior leads  hypo rca, mod lvd 0 40 1.4 13.8 7600 1.96 41.7 
55 1 1 7 3 1 1 0 0 0 0 0 0 0 1 1 0 0 0  3 0 80 130 80 1 1 1 222 7.4  st ele anterior leads  hypo lad, n lvd 0 18 1.2 14 11600 2.49 42.3 
42 2 0 7 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0  20 0 86 130 80 1 1 1 86 4.7  st dep inferior leads  no rema, n lvf 0 19 0.9 13.2 7700 3.3 39.5 
39 1 0 7 0 0 0 0 0 0 0 0 0 0 1 1 1 1 1  22 0 76 120 80 1 1 1 273 11  st dep anterior leads hypo lad, n lvf 0 18 1.2 17 11200 2.9 45 
63 1 1 7 20 1 3 1 0 0 0 0 0 1 1 0 1 0 0  18 0 80 150 100 1 1 1 198 7 st ele inferior leads  hypo rca, n lvf 1 33 1.3 12.7 10500 2.4 38 
50 1 0 7 0 0 0 0 0 0 0 0 0 0 1 1 0 0 0  4 0 80 120 80 1 2 1 80 5 st ele inferiorleads evolved  hypo rca, n lvf 0 23 1 12.5 9900 3.2 38.2 
40 2 0 7 0 0 0 0 0 0 0 0 0 1 1 0 0 0 0  2.5 0 72 130 90 1 1 1 113 4.8  st ele anterior leads evolved  hypo rca, mod lvd 0 27 1.4 11.2 9800 1.9 33.4 
60 1 0 7 0 0 0 0 0 0 0 0 0 0 1 0 0 1 0  4 0 54 130 90 1 1 1 201 9.2  st ele inferior leads evolved  hypo rca, mild lvd  0 24 1.2 15.7 4000 2 45.4 
71 2 0 7 0 0 0 0 0 0 0 0 0 1 1 0 0 0 0  6 0 94 170 90 1 1 1 66 6 st dep lateral leads hypo rca, n lvf 1 19 0.8 11.4 9500 1.9 34.8 
60 1 1 7 6 1 1 0 0 0 0 0 0 1 1 0 0 0 0  12 0 70 170 80 1 1 1 165 6 st ele inferior leads evolved  hypo rca, n lvf 1 40 1.5 12.7 10000 2 40 
57 1 0 7 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0  10 0 86 140 90 1 1 1 89 5.9  st dep lateral leads no rema, n lvf 0 30 1 13.3 6800 2.38 41 
45 1 1 7  1 1 0 0 0 0 0 0 1 1 0 0 1 0  4 0 72 160 90 1 1 1 125 7.9 st dep inferolateral leads hypo rca, n lvf 1 15 0.8 12.9 12900 3 39 
38 1 0 7 0 0 0 0 0 0 0 0 0 0 1 0 0 1 0  1 0 112 160 120 1 2 1 172 6  st ele anterior leads  hypo Lad, mild lvd  0 25 1.2 16.1 15600 3 49 
60 1 0 7 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0  24 0 96 110 90 1 1 1 180 6.4  st ele inferior leads evolved  hypo rca , mild lvd 1 21 0.9 11.6 5800 3.5 36.4 
45 2 0 7 0 0 0 0 0 0 0 0 0 0 1 1 0 1 0  2 0 56 100 80 1 1 1 264 7.4  st ele inferior leads  hypo rca, n lvd 0 28 1.2 15.2 12300 3.7 46 
55 1 0 7 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0  20 0 86 140 80 1 1 1 93 5  st dep anterior leads no rema, n lvf 0 32 1.1 11.5 7700 1.75 33.5 
60 2 0 8 0 0 0 0 0 0 0 0 0 1 1 0 0 0 0  3 0 45 70 50 2 1 1 151 6  st ele inferior leads 2 blovk  hypo lad, sever LVD 0 33 1 9.9 12600 2.56 31 
56 2 1 7 2 1 1 0 0 0 0 0 0 1 1 1 0 1 0  23 0 86 200 120 1 1 1 320 7.1  st dep anterior leads  no rewma, n lvf 0 26 1.3 13.5 5500 1.85 40 
60 1 0 7 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0  21 0 100 130 90 1 2 1 152 5.6  st ele anterior leads evolved  hypo lad, mod lvd 0 35 1.3 10.5 12900 3.76 30.6 
44 2 0 7 0 0 0 0 0 0 0 0 0 1 1 1 0 0 0  12 0 90 110 90 1 1 1 123 6  st dep anterior leads  no rwma , n lvf 1 21 1.2 15.9 13900 3 46.3 
53 1 0 3 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0  2 0 70 120 100 1 1 1 113 5  st ele anterior leads  hypo lad, mod lvd 0 42 1.3 12.8 15300 3.5 39.1 
54 1 0 9 0 0 0 0 0 0 0 0 0 0 1 1 0 1 0  1 0 74 110 80 1 1 1 126 6  st ele inferior leads  hypo rca n lvf 0 23 1 14 10400 3.5 42 
72 1 1 7 25 1 3 0 0 0 0 0 0 1 1 0 0 0 0  4 0 120 150 100 1 2 1 400 7.3  LBBB hypo lad sever LVD 0 48 1 11.6 16500 4 30.1 
57 1 1 9 4 1 1 0 0 0 0 0 0 1 1 1 0 1 0  1 0 70 150 90 1 1 1 140 5.5  st dep anterior leads hypo lad, n lvf 1 15 1.1 14.6 10200 2 41 
72 1 0 8 0 0 0 0 0 0 0 0 0 1 1 0  1 0  4 0 78 170 110 2 1 1 396 6.4  st ele inferior leads evolved  hypo rca n lvf 1 17 1.4 14.4 16500 3.06 41 
50 1 1 9 2 1 1 0 0 0 0 0 0 1 1 1 0 0 0  3 0 76 120 90 1 1 1 252 7.9  st dep anterior leads hypo rca n lvf 1 21 1.3 13.5 14400 3.3 43 
65 1 1 7 25 1 2 0 0 0 0 0 0 1 1 0 0 0 0  0 0 130 160 110 2 2 1 437 10  st dep anterior leads  hypo lad sever LVD 1 34 1.2 11.8 11400 3.7 38.7 
64 2 0 7 0 1 0 0 0 0 0 0 0 0 0 0 1 0 1  1 0 86 70 0 1 1 1 247 5.8  st ele anterior leads  hypo lad mild lvd  1 31 1.4 11.7 15000 2.9 28.8 
57 1 1 8 5 1 1 0 0 0 0 0 0 1 1 0 0 0 0  0 0 66 120 70 1 1 1 197 6.2  st dep lateral leads  no rwma n lvf 0 35 1.1 12.5 7400 2.6 37.8 
56 2 1 7 4 0 1 0 0 0 0 0 0 1 1 0 0 0 0  1 0 104 130 90 1 2 1 384 7.7  st ele anterior leads  hypo lad sever LVD 0 44 1.3 13.5 8900 3.24 42.4 
53 2 1 7 1 1 1 0 0 0 0 0 0 0 1 0 0 0 0  5 0 94 90 70 1 1 1 128 7.8  st ele anterior leads  hypo lad mild lvd  0 27 1 12 10500 2.56 30 
59 1 1 7 2 1 1 0 0 0 0 0 0 0 0 0 0 0 0  2 0 96 110 90 2 1 1 210 8.4  st ele anterior leads hypo lad mild lvd  0 17 0.9 13.3 8300 2.95 39.9 
63 1 0 8 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0  8 0 42 110 90 2 2 1 350 5.6  st ele anterior leads evolved  hypo lad, mod lvd 0 48 1.4 13.98 11800 4 40.5 
50 1 1 7 2 1 1 0 0 0 0 0 0 1 1 1 1 1 0  6 0 72 130 94 1 1 1 100 5.6  st dep inferior leads hypo rca n lvf 1 45 1.2 17.2 14300 3.44 45.5 
46 1 1 7 7 1 1 0 0 0 0 0 0 0 1 1 1 1 1  3.5 0 96 100 70 1 1 1 185 7.6  st ele anterior leads evolved  hypo Lad, mild lvd  0 36 0.6 12.7 12100 2.2 36 
70 1 1 8 6 1 1 0 0 0 0 0 0 1 1 0 0 0 0  4.5 0 88 140 90 1 1 1 307 6.6  st dep inferior leads hypo rca, mild lvd  1 22 0.7 11.8 12000 2.75 39.2 
50 2 1 13 6 1 1 0 0 0 0 0 0 1 1 1 0 0 0  1 0 94 130 90 1 2 1 592 7.8  st ele inferior leads  hypo rca, mild lvd  0 29 1 11.5 13300 3.863 35.8 
69 1 1 7 20 1 2 0 0 0 0 0 0 1 1 0 0 0 0  14 0 88 140 90 1 1 1 178 6.8  st ele inferior leads evolved  hypo rca, n lvf 1 18 0.6 13.1 9000 2.8 43.8 
65 1 1 7 10 1 1 0 0 0 0 0 0 1 1 0 1 0 0  5 0 114 150 110 1 2 1 378 9  st dep anterior leads hypo lad, n lvf 0 49 1 11 16000 3.5 35 
53 2 1 8 4 1 1 0 0 0 0 0 0 0 1 0 0 0 0  3 0 94 120 90 2 1 1 328 9  st ele inferior leads  hypo rca, mild lvd  0 25 1.4 13.7 9300 3 41.5 
63 1 1 8 15 1 2 0 0 0 0 0 0 1 1 0 0 0 0  20 0 102 140 96 1 1 1 325 7.5  st dep lateral leads  hypo rca, mild lvd  0 43 1.4 13.5 4600 1.9 39.4 
74 2 0 7 0 0 0 0 0 0 0 0 0 1 1 1 1 0 0  2 0 98 150 100 1 2 1 216 6.1  st ele inferolateral leads evilved  no rwma, n lvf 1 32 1.5 13.5 4800 2.1 41.7 
62 1 1 7 10 1 1 0 0 0 0 0 0 1 1 1 0 1 0  24 0 98 180 100 1 1 1 213 7.4  st dep anterior leads  hypo Lad, mild lvd  1 20 0.8 14.1 4400 2 42.1 
42 1 0 7 0 0 0 0 0 0 0 0 0 0 1 1 1 1 1  6 0 96 146 100 2 1 1 254 7  st dep lateral leads  no rwma, n lvf 1 13 1.1  16.4 8400 4 46 
65 1 0 7 0 0 0 0 0 0 0 0 0 1 1 0 0 1 0  5 0 112 200 120 2 2 1 180 8.4  st dep anterior leads  hypo lad, n lvf 1 32 1.3 12.3 7000 3 38.5 
62 2 1 13 10 1 1 1 0 0 0 0 0 1 0 0 0 0 0  1 0 150 220 110 2 2 1 537 7.7  st dep anterior leads  hypo lad, n lvf 1 28 0.8 13.8 12400 2.88 44.2 
47 1 1 7 10 1 1 0 0 0 0 0 0 1 1 0 0 1 0  21 0 86 140 80 1 1 1 195 6.1  st dep inferior leads  no rwma, n lvf 0 21 1.3 11.2 9500 3.89 35 
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Abbreviations used in master chart 
DM +/- 1= diabetes persent, 0= absent  
Sex : 1 = male, 2 =female 
Duration of hospital in days  
Duration of diabetes mellitus in years 
Treatment history 1=Oral hypoglycemic agents, 2=lnsulin, 3=Both 
Target organ damage 
Retinopathy 1 =present, 0=absent  
Nephropathyl =present,0=absent  
Previous cardiac events 1 =present,0= absent 
 Cerebrovascular events 1 =present, 0= absent  
Prior diabetic complications 1=present, 0= absent 
 Risk factors 
HTN-hypertension, 1=present, 0=absent  
Dyslipidemia,1=present,0=absent  
Smoking, 1 =present,0=absent  
Alcoholism, 1=present,0=absent  
Stress, 1=present,0=absent  
Obesity, 1=present,0=absent 
Chest pain and dyspnea in hours  
Heart rate in rates/minute  
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Blood pressure in mm/hg 
Cardiovascular system:  normal=1, 2=abnormal  
Respiratory system examination 1=normal, 2=abnormal 
Abdominal examination 1= normal,2=abnormal 
Investigations: 
Hb-Hemoglobin: gm% 
HCT- Haematocrit: % 
Total count and platelet count: cells/mm3 
Bt-bleeding time and ct- clotting time in minutes 
RBS- Random blood sugar: mg% 
HBA1C: in% 
Urea and creatinine: mg/dl 
Cardiac enzymes (CPK) positive =1, negative=0 
Adverse cardiac events: 
0 = normal 
1 =left ventricular failure 
2=arrhythmias 
3=cardiogenic shock 
Condition at discharge: 
Recovered satisfactorily =1; residual dysfunction =2 ;death =3 
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Diagnosis: 
STEMI=1,NSTEMI=2, unstable angina=3 
KEY: 
• DM – Diabetes Mellitus 
• dur of hos – duration of hospital stay 
• dur of DM – duration of Diabetes Mellitus 
• type – treatment received for diabetes( OHA,insulin or both) 
• retinop – retinopathy 
• PVD – peripheral vascular disease 
• pre car e – previous cardiac events 
• nephro – nephropathy 
• CVA – cerebrovascular accidents 
• DM comp – diabetic complications 
• HT – hypertension 
• dyslip – dyslipidemia 
• alsoho – alcoholic 
• cp hrs – chest pain in hours 
• HR – heart rate 
• BP SYS – systolic blood pressure 
• BP DIA – diastolic blood pressure 
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• CVS – cardiovascular system 
• RS – respiratory system 
• PA – per abdomen 
• card enzy – cardiac enzymes 
• S Creat – serum creatinine  
• PCV – packed cell volume 
• CT – clotting time, BT – bleeding time 
• ADV Car Events – adverse cardiac events 
• cond @ dis – condition at discharge 
 
 
